LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Carl Zeiss Acquires Bio-Rad's Cell Science Division

By Biotechdaily staff writers
Posted on 15 Jun 2004
In a move that will enlarge its microscopy business, Carl Zeiss (Oberkochen, Germany) has acquired the Cell Science Division (Hemel Hempstead, UK) of Bio-Rad Laboratories, Inc. (Hercules, CA, USA). Terms were not disclosed.

This strategic move is part of the ongoing investment in enhancing the application expertise at Carl Zeiss, according to the company. The acquisition is expected to accelerate future advances in confocal and multiphoton microscope instrumentation with Carl Zeiss as the major driving force in the field.

"Today, Carl Zeiss stands for high-end laser scanning microscopes that are benchmark solutions for advanced applications in 3-D microscopy,” said Dr. Ulrich Simon, head of the microscopy business group at Carl Zeiss. "Joining our forces will strengthen our relationship with Zeiss and Bio-Rad customers, and will allow a considerable additional refinement of both companies' worldwide service and support network.”





Related Links:
Carl Zeiss
Bio-Rad

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Drug Test Kit
DrugCheck 3000
New
Integrated Biochemical & Immunological System
Biolumi CX8

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
15 Jun 2004  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
15 Jun 2004  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
15 Jun 2004  |   BioResearch